Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

World shares rise on recovery hopes, following stellar November

12/01/2020 | 12:10am EST

(Adds details, updates prices, changes dateline)

* World shares up 0.4% after strong European open

* China factory activity growth hits 10-yr high in Nov

* U.S. dollar weakens, risk-related currencies up

* Oil slips after OPEC+ talks delay, copper up

MILAN/SYDNEY, Dec 1 (Reuters) - World shares edged up to just below record peaks on Tuesday after robust China data boosted expectations of a recovery from the COVID-19 downturn and as drugmakers seek fast approval for their vaccines and authorities look set to keep stimulus support.

Bets of more easing from the Fed in the United States to help the pandemic-hit economy through the winter weighed on the dollar, as riskier currencies rose, while crude prices missed out on the bounce after OPEC+ countries delayed a decision on output cuts.

The MSCI world equity index, which tracks shares in 49 countries, was up 0.4% by 0849 GMT.

Breakthroughs in vaccine developments from top drugmakers Pfizer, Moderna and AstraZeneca last month along with a market-friendly outcome of the U.S. presidential election helped the index score its best month on record, up 12% to new all-time peaks.

"We believe the rally can continue, with the current pipeline of expected vaccine rollouts in line with our central scenario of widespread availability in the second quarter of 2021," said Mark Haefele, Chief Investment Officer at UBS Global Wealth Management in Zurich.

"We also believe that a divided U.S. government - which looks the most likely outcome - is no impediment to a rising market," he added.

In Europe the pan-regional STOXX 600 benchmark was up 0.7% in early deals, while U.S. stock index futures also pointed to a strong start on Wall Street with investors focusing on November manufacturing surveys from Europe and the United States.

Earlier the MSCI's broadest index of Asia-Pacific shares outside Japan added 1.3%, while China's blue-chip CSI300 index jumped 2.2% after a business survey showed on Tuesday activity in China's factory sector accelerated at the fastest pace in a decade in November.

Japan's Nikkei rose 1.3% while Australia's S&P/ASX 200 gained 1.1% after Australia's central bank said the country's economy would need fiscal and monetary support "for some time".

"What we are seeing today is that upward trend reasserting itself, given the positive news on the vaccine front, China's growth picking up, and the tremendous faith in the ability of central banks to keep the markets afloat," said Stephen Miller, market strategist for GSFM Funds Management.

Moderna Inc applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns.

In foreign exchange markets, the dollar was under pressure after closing out its worst month since July with a little bounce and as investors reckon on even more U.S. monetary easing.

The dollar index was last down 0.3% to 91.706.

In a speech released late on Monday, Fed chair Jerome Powell said a slowing recovery and a surging pandemic meant the U.S. was entering a "challenging" few months, with the potential deployment of a vaccine still facing hurdles.

Elsewhere sterling hit a three-month high as traders clung to hopes for a Brexit trade deal before the year's end, while risk-related currencies such as the Canadian and Aussie dollar rose against the greenback.

The U.S. bond market was steady, as the U.S. Congress began a two-week sprint to secure government funding and avoid a possible shutdown amid the coronavirus pandemic.

U.S. 10-year yields were up slightly at 0.8438%.

Germany's benchmark 10-year bond yield hovered near three-week lows, while southern European debt yields kept record lows in sight ahead of next week's European Central Bank meeting.

Germany's Bund yield was a touch lower in early trade at -0.574%, close to Monday's three-week low of -0.60%.

Reflecting the upbeat mood, copper prices rose with Shanghai prices hitting a more than eight-year high, helped by the robust Chinese data.

Oil prices however were slightly lower after leading producers delayed talks on 2021 output policy, while the coronavirus pandemic continued to sap fuel demand.

OPEC+ delayed talks on output policy for next year until Thursday, three sources told Reuters, as key players still disagreed on how much oil they should pump amid weak demand/

Brent crude futures were 0.2% lower at $47.8 a barrel, while U.S. crude also eased back to $45.31.

(Reporting by Danilo Masoni in Milan and Paulina Duran in Sydney; Editing by Mike Collett-White)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 1.66% 7777 Delayed Quote.6.19%
EURO / BRITISH POUND (EUR/GBP) -0.01% 0.88927 Delayed Quote.-0.82%
EURO / US DOLLAR (EUR/USD) -0.02% 1.21665 Delayed Quote.-0.41%
LONDON BRENT OIL -1.92% 55.07 Delayed Quote.8.61%
MODERNA, INC. -1.47% 131.02 Delayed Quote.25.41%
MSCI WORLD INDEX (STRD, UHD) -0.36% 2755.663 Real-time Quote.2.81%
NIKKEI 225 -0.44% 28631.45 Real-time Quote.4.33%
STOXX EUROPE 600 -0.57% 408.54 Delayed Quote.2.38%
UBS GROUP AG -0.68% 13.15 Delayed Quote.5.45%
WTI 0.00% 52.063 Delayed Quote.10.00%
All news about MODERNA, INC.
03:40pMODERNA : U.S. CDC says 21.8 million doses of COVID-19 vaccines administered
01/23MODERNA : U.S. CDC says 41.4 mln doses of COVID-19 vaccines distributed, 20.5 ml..
01/22PFIZER : Provinces doing 'extraordinary' job to avoid wasting doses of COVID-19 ..
01/2239.9 MLN DOSES OF COVID-19 VACCINES : U.s. cdc
01/22CDC : 10 life-threatening reactions linked with Moderna COVID-19 vaccine
01/22MODERNA : Lucky few hit COVID-19 vaccine jackpot for rare extra doses
01/22MODERNA : Severe allergic reactions to Moderna vaccine appear rare -CDC report
01/22AstraZeneca's initial EU delivery volumes of COVID-19 vaccine to fall short
01/22MODERNA : BofA Securities Adjusts Moderna PT to $140 From $130, Maintains Neutra..
01/22Where Our Current Covid-19 Vaccination Rate Will Take Us
More news
Financials (USD)
Sales 2020 512 M - -
Net income 2020 -571 M - -
Net cash 2020 2 597 M - -
P/E ratio 2020 -107x
Yield 2020 -
Capitalization 51 846 M 51 846 M -
EV / Sales 2020 96,2x
EV / Sales 2021 4,40x
Nbr of Employees 1 100
Free-Float 90,0%
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 137,27 $
Last Close Price 131,02 $
Spread / Highest target 41,2%
Spread / Average Target 4,77%
Spread / Lowest Target -47,3%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.25.41%51 846
LONZA GROUP AG5.34%50 271
CELLTRION, INC.-13.65%38 245
SEAGEN INC.4.35%33 059